en

PRODUCT DETAIL

FEIBA 50 U/ml

Code 01571
MA number 16/0225/13-S
Product Form: plv iio 1x1000 U+20 ml solv.(liek.inj.skl.+prísl.+Baxject II Hi-Flow)
MA Status: D - Marketing Authorisation valid for an unlimited period
Type of procedure: National
Therapeutic Class: 16 - ANTICOAGULANTIA (FIBRINOLYTICA, ANTIFIBRINOL.)
ATC:
B BLOOD AND BLOOD FORMING ORGANS
B02 ANTIHEMORRHAGICS
B02B LOCAL HEMOSTATICS, COMBINATIONS
B02BD Blood coagulation factors
B02BD03 Factor VIII inhibitor bypassing activity
Shelf life: 24
Container: glass vial
Route of admin.: Intravenous use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 30.12.1980
Pediatric indication: Yes
Pediatric posology: Yes
SPC: SPC_FEIBA 50 U_ml_plv inj_12.2020.doc  
PIL: PIL_FEIBA 25 Uml_50 Uml_05.2022.pdf  
Safety feature Yes
Data update: 19.05.2020
eu-flag.png sk-flag.png